Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the uael domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the kirki domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114
Imagion Biosystems March 2021 Investor Newsletter | Imagion Biosystems
Search
Twitter-square Facebook-square Linkedin Youtube

Imagion Biosystems March 2021 Investor Newsletter

Imagion Biosystems March 2021 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its March 2021 Investor Newsletter. The newsletter details recent new company developments and activities, including:

  • Message from the CEO, Mr Robert Proulx
  • Study design at a glance – MagSense® HER2 breast cancer Phase 1 study
  • CSIRO funding received to jump start prostate cancer project
  • Prostate Cancer Q&A with Professor Lisa Horvarth, IBX Scientific Advisory Board and Professor Roger Daly, Monash University
  • Imagion Biosystems 2020 Annual Report
  • How to exercise your options

The investor newsletter can be viewed here. Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD

Related Articles

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube